Table 1.
Garrigós-Pedrón M. (2018) [14] | Nagata K. et al. (2018) [19] | Craane B. et al. (2012) [20] | Guarda-Nardini L. et al. (2011) [18] | Kalamir A. et al. (2011) [21] | Ismail F. et al. (2007) [22] | |
---|---|---|---|---|---|---|
Item 1 | ● | ● | ● | ● | ● | ● |
Item 2 | - | ● | ● | - | ● | - |
Item 3 | ● | ● | ● | ● | ● | ● |
Item 4 | - | ● | - | - | - | - |
Item 5 | - | - | - | - | - | - |
Item 6 | ● | - | ● | - | ● | - |
Item 7 | ● | ● | ● | - | ● | ● |
Item 8 | - | ● | ● | - | ● | - |
Item 9 | ● | ● | ● | ● | ● | ● |
Item 10 | ● | ● | ● | ● | ● | ● |
TOTAL | 6/10 | 8/10 | 8/10 | 4/10 | 8/10 | 5/10 |
Items: 1 = Subjects were randomly allocated to groups; 2 = Concealed allocation; 3 = Groups were similar at baseline; 4 = Blinding of all subjects; 5 = Blinding of all therapists; 6 = Blinding of all assessors; 7 = Measures for at least one key outcome were obtained from more than 85% of the subjects; 8 = Intention to treat analysis; 9 = Results of between-group statistical comparisons reported for at least one key outcome; 10 = Provides both point measures and measures of variability for at least one key outcome.● = present item